Savannah DeMelo’s Lawsuit Exposes the Legal Fault Line Behind the “Team Doctor”

Case Analysis | September 15, 2026 (Updated September 16, 2026)

The phrase “team doctor” is doing a lot of work.

To an athlete, the doctor may look like part of the team. The club selected the medical provider. The physician treats players, communicates with team staff, makes return-to-play decisions and may even carry the title of team chief medical officer.

Legally, however, the arrangement can look very different.

The physician may work for a hospital or outside medical group. The hospital may have a services agreement with the club. The club may rely on the physician’s medical judgment without employing the physician at all. And, under the National Women’s Soccer League’s collective-bargaining agreement, none of that changes the most important relationship: the health-care professional’s primary professional duty is to the player-patient.

That architecture is now at the center of Savannah DeMelo’s new lawsuit.

The Racing Louisville midfielder sued UofL Health and two affiliated physicians in Jefferson Circuit Court on September 15, 2026, alleging that they negligently failed to diagnose and treat a cardiac condition before she suffered cardiac arrest during an NWSL match in Seattle almost exactly one year earlier. One of the defendants, Dr. Jennifer Daily, serves as Racing Louisville’s chief medical officer but is not a club employee; she works with the team through its relationship with UofL Health. Racing Louisville itself is not named as a defendant.

The lawsuit is new. A judicial decision is not.

That distinction matters.

Nothing yet.

This is a newly filed complaint, not a verdict, summary-judgment ruling, motion-to-dismiss decision or even a preliminary-injunction proceeding. No court has found that DeMelo’s doctors missed a diagnosable condition. No court has concluded that anyone negligently cleared her to play. No court has determined that a different diagnostic or treatment decision would have prevented her cardiac arrest.

At this stage, those are DeMelo’s allegations.

Public reporting says her complaint alleges that UofL Health and the physicians failed to properly diagnose and treat the heart condition that preceded her September 14, 2025 cardiac arrest. She seeks damages including medical expenses, lost income, permanent impairment, physical and mental suffering and diminished enjoyment of life.

That procedural posture substantially limits what can responsibly be said about who should win.

But it does not limit what makes the case important.

Because even before anyone takes a deposition, the dispute exposes a structural question that extends well beyond one player and one soccer club:

Who owns the medical risk when a professional team outsources the doctors but relies on those doctors to decide whether its athletes can play?

The public record predating the lawsuit is unusually important because it shows why this case is unlikely to turn on the simple fact that a catastrophic event eventually occurred.

DeMelo had already disclosed significant health issues months before her cardiac arrest.

She was diagnosed with Graves’ disease and hyperthyroidism in late 2024. In a May 2025 interview with ESPN, DeMelo described periods in which her heart felt as though it was “beating so fast” that she struggled to breathe and sustain the physical demands of a match. She said her resting heart rate had at one point roughly doubled from her ordinary baseline.

On March 22, 2025, during a match against Bay FC, DeMelo became dizzy, experienced chest tightness, had difficulty breathing and was eventually stretchered from the field and taken to a hospital.

But the public medical narrative at the time was not that doctors had discovered an untreated cardiac arrhythmia.

According to the ESPN report, Daily and Racing Louisville helped DeMelo obtain endocrinology care after her initial thyroid diagnosis. DeMelo was prescribed medication intended in part to control her heart rate, saw an endocrinologist regularly and underwent bloodwork approximately every three weeks. Her preseason thyroid testing had been normal. The March episode was publicly attributed to a medication imbalance that caused her heart rate to become too slow for the demands of professional competition, and her medication was adjusted.

Six months later, DeMelo collapsed during Racing Louisville’s September 14 match at Seattle.

The game was abandoned. Racing said she received immediate on-field medical treatment, was stable and alert, and was transported to a hospital. DeMelo herself later thanked the medical personnel who responded to the emergency.

One year later, DeMelo publicly described what happened in substantially more serious terms: she said an undiagnosed cardiac arrhythmia caused her to suffer cardiac arrest. Reporting on the new lawsuit says she was ultimately diagnosed and treated for ventricular tachycardia.

That distinction—between a previously understood thyroid-and-medication problem and the cardiac condition DeMelo now alleges should have been diagnosed—is likely to become the center of the litigation.

A terrible medical outcome does not establish medical malpractice.

Kentucky law requires a medical-malpractice plaintiff to establish that the care fell below what was expected of a reasonably competent practitioner and that the departure from the standard of care proximately caused the claimed injury. The Kentucky Supreme Court has repeatedly emphasized that complicated questions of medical causation ordinarily require expert testimony rather than a jury simply inferring negligence from the eventual injury.

For DeMelo, that likely means the litigation will eventually become much more granular than the public chronology.

The important questions will include what symptoms her physicians knew about; what testing was performed after the March episode; what that testing showed; whether additional cardiac testing was indicated; whether an arrhythmia was reasonably detectable at the relevant time; whether her thyroid disease or medication could reasonably explain the symptoms physicians observed; what specialists recommended; what information was available when she was cleared to continue playing; and, critically, whether a different course would probably have prevented the September cardiac arrest.

That final point is easy to overlook.

Even if DeMelo establishes that additional testing should have occurred, she still must connect that failure to the injury. Kentucky’s Supreme Court made that distinction especially clear in Saint Elizabeth Medical Center v. Arnsperger: breach and causation are separate questions, and when the causal chain turns on complex medicine, expert proof is essential.

Kentucky reinforces that expert-centered system before a malpractice case gets very far. KRS 411.167 generally requires a medical-malpractice plaintiff to file a certificate stating that the case has been reviewed in consultation with a qualified expert who found a reasonable basis to commence the action, subject to specified exceptions.

In other words, the decisive evidence in DeMelo will probably not be the video of her collapse.

It will be the medical record before it.

The strongest defense is visible even before an answer is filed.

The defendants can point to a documented course of treatment rather than indifference to DeMelo’s symptoms. She had been diagnosed with Graves’ disease. She had endocrinology care. Her medication was monitored. She received recurring bloodwork. Her preseason testing was reportedly normal. And the March incident generated additional medical evaluation and an adjustment to a medication regime believed at the time to explain what happened.

That does not establish appropriate care.

But it makes this a much different case from one in which an athlete repeatedly reported cardiac symptoms and nobody investigated them.

Medical negligence is judged from what a reasonably competent practitioner should have done with the information available then, not by working backward from a cardiac arrest and assuming someone necessarily should have predicted it.

That is likely where the case will be fought.

DeMelo’s experts will try to show that the pattern of symptoms, history and available clinical information should have triggered further cardiac investigation before she continued professional competition. The defense will likely argue that the care was reasonable based on what physicians knew, that the symptoms could reasonably have been attributed to the diagnosed thyroid and medication issues, or that the later arrhythmia either was not detectable earlier or would not have been prevented by the additional measures DeMelo says should have occurred.

The difference between those stories will probably live in expert reports, diagnostic records and physician depositions—not headlines.

This is where the case becomes much larger than an ordinary malpractice dispute.

The current NWSL-NWSLPA collective-bargaining agreement expressly confronts the divided loyalties that can arise in professional sports medicine.

Section 11.3 says the “primary professional duty” of health-care professionals secured by a team or the league is to the player-patient—even when the physician, hospital, clinic or medical group has been retained by the team to treat players.

That is remarkably direct.

The club may choose the medical infrastructure. The patient remains the athlete.

The rest of the CBA shows why the distinction matters.

The agreement gives the team physician the authority to determine whether a player is fit to train, play or return to play, and ordinarily requires that determination to be documented in writing. It gives players a mechanism to challenge fitness determinations through their own physicians and, if disagreement remains, an independent panel physician.

It separately requires NWSL players to have access to cardiac screening consistent with U.S. Soccer protocols. Beginning with the 2025 season—the year of DeMelo’s cardiac arrest—each team also had to secure at least two physicians, including a designated chief medical officer, and maintain a medical-provider agreement or association with a medical center. Teams are specifically required to establish a relationship with a cardiologist for referrals.

None of those provisions proves DeMelo’s negligence claim.

Nor does a CBA provision automatically establish Kentucky’s tort standard of care.

But the agreement matters because it eliminates one potentially muddy conceptual issue: professional sports medicine is not supposed to subordinate the athlete-patient’s medical interests to the competitive interests of the club that arranged the care.

That principle will loom over the factual dispute about what happened here.

Racing Louisville is conspicuously absent from the complaint.

Public reporting says Daily is Racing’s chief medical officer but is employed through UofL Health rather than directly by the club. The physicians named in the suit similarly are not Racing employees.

That may help explain why DeMelo’s current theory focuses on medical negligence by the providers rather than negligence by the club.

But employment labels are not necessarily the end of institutional-liability questions.

Kentucky recognizes forms of agency liability in the medical context. In Paintsville Hospital Co. v. Rose and, more recently, Sneed v. University of Louisville Hospital, Kentucky courts have examined whether physicians who were not technically hospital employees nevertheless could be treated as apparent or ostensible agents based on how the medical relationship was presented to the patient. Sneed ultimately rejected liability on its facts because the hospital had adequately disclosed the physicians’ independent status, but the Kentucky Supreme Court reaffirmed that the inquiry turns on more than the payroll designation alone.

The facts here are different. This is professional sports, not a conventional patient walking into a hospital.

But that makes the underlying agreements more—not less—interesting.

Discovery could illuminate who selected the physicians, who established medical protocols, who controlled communications, what UofL Health promised Racing it would provide, what authority accompanied Daily’s role as chief medical officer, and how return-to-play decisions moved among physician, player and club.

The provider agreement may ultimately become one of the most important documents in the case even though the club that signed it is not presently being sued.

And there is already a business consequence. Reporting says Racing Louisville does not expect to continue using UofL Health as its medical partner after the current season. Neither that decision nor the lawsuit establishes wrongdoing, and the club has declined to comment on the litigation.

The filing date creates another procedural issue.

DeMelo’s cardiac arrest occurred on September 14, 2025. The lawsuit was filed September 15, 2026.

Kentucky generally gives a plaintiff one year to bring a medical-malpractice action after the claim accrues. But the statute does not mechanically say the clock always begins on the date the physical harm occurs. KRS 413.140 applies a discovery rule: accrual occurs when the relevant “injury” is discovered or reasonably should have been discovered.

Kentucky decisions distinguish discovering that something bad happened from discovering facts connecting that harm to possible medical wrongdoing. A 2026 Kentucky Court of Appeals decision reiterated that distinction, explaining that in the malpractice context “injury” refers to the alleged wrongdoing rather than simply the underlying medical harm.

That does not mean DeMelo’s complaint is necessarily timely.

It means the one-year-and-one-day calendar alone does not answer the question.

If the defendants raise limitations, the critical issue could become when DeMelo possessed enough information to know—or reasonably should have known—not merely that she suffered cardiac arrest, but that the arrest arguably resulted from an earlier failure to diagnose or treat her condition.

That can be a highly fact-specific inquiry. It is also exactly the kind of threshold issue that can reshape a case before anyone reaches the substantive negligence allegations.

For now, DeMelo establishes no precedent about NWSL medical care.

It does not establish that her physicians should have diagnosed the arrhythmia sooner.

It does not establish that Racing Louisville violated the CBA.

It does not establish that an outside medical provider becomes the legal agent of a team merely because its physician carries a team title.

And it does not establish that cardiac arrest after a return-to-play decision is evidence of negligent clearance.

Those questions remain open.

That restraint matters because there is a temptation in athlete-health cases to collapse two very different propositions: “something catastrophic happened” and “someone must have negligently allowed it to happen.”

Tort law requires the bridge between them.

A lawsuit does not need to create precedent to change behavior.

Professional clubs, medical systems and leagues have every reason to study this case now because the same structural arrangement exists throughout sports: the team assembles a medical network, outside providers furnish much of the care, and athletes rely on those providers while the organization simultaneously relies on their fitness determinations.

That arrangement creates several places where ambiguity becomes risk.

Who owns the diagnostic follow-up after an abnormal event? Who confirms that a specialist actually received all relevant records? Who reconciles competing explanations for symptoms? Who makes the final fitness decision? What must be documented? When is an independent second opinion triggered? How does a hospital-provider contract allocate liability and insurance? And, most importantly, does the operational reality match the principle written into the CBA—that the physician’s allegiance runs first to the patient?

Those are not abstract compliance questions when the employee’s job is to push her cardiovascular system to elite limits for 90 minutes.

In ordinary employment, a fitness-for-duty decision determines whether someone comes to work. In professional sports, it can determine whether someone enters an environment designed to push the human body to its edge.

That makes the quality of the decision unusually consequential.

This is also not a conventional lawsuit brought by a former athlete whose playing career is plainly over.

DeMelo has returned to full training, and reporting indicates that she and Racing Louisville have verbally agreed on a contract extension pending league approval.

That cuts in multiple directions.

A successful return could reduce some future lost-income theories. But it would not eliminate claims for past lost earnings, medical costs, pain and suffering, impairment or other damages resulting from a year away from competition.

And professional-sports damages can become unusually difficult to quantify.

Lost matches are one thing. Lost national-team opportunities, performance bonuses, endorsements, future contracts and career trajectory are another. The further damages analysis moves from compensation that was contractually guaranteed to opportunities an athlete might have earned, the more causation and reasonable certainty become important.

DeMelo’s ability to play again therefore does not make damages disappear.

It makes them more interesting.

The immediate litigation will be far less dramatic than the event that produced it.

The defendants will respond to the complaint and may raise threshold defenses, including any statute-of-limitations or pleading issues they believe are available. The parties then will likely move into document discovery and depositions centered on DeMelo’s medical history, testing, specialist referrals, medication management, communications among medical professionals and Racing personnel, and each fitness-to-play decision preceding September 14, 2025.

Expert testimony should eventually dominate both sides of the case. That evidence will determine whether the alleged arrhythmia reasonably should have been identified, what additional testing or treatment the applicable standard required, and whether those steps probably would have prevented the cardiac arrest.

The Racing-UofL Health medical-services arrangement also bears watching. Racing is not a defendant, but that does not mean its records or witnesses will remain outside the case.

Eventually, the dispute may reach summary judgment, settlement or trial.

For now, however, its broader significance is already clear.

Professional sports has spent years trying to resolve the inherent tension created when the person deciding whether an athlete can compete is part of a medical system assembled by the organization that benefits when the athlete competes.

The NWSL’s CBA supplies the principle in unusually plain language: the doctor’s first duty is to the player.

DeMelo may now test what that principle means when the institutional structure is complicated—and the consequences of getting the medical judgment wrong are measured in something far more serious than missed playing time.

The jersey says team. The medical duty says patient.

September 16, 2026

There is already a significant institutional development arising alongside Savannah DeMelo's lawsuit.

Multiple reports now say Racing Louisville FC has decided not to continue working with UofL Health as its medical partner after the current season. USA Today initially reported, citing a person familiar with the arrangement, that the club was not expected to retain UofL Health. The Guardian subsequently reported that sources close to DeMelo and the club said Racing had already determined the relationship would end.

That does not establish why the partnership is ending. Racing Louisville has not publicly said that DeMelo's lawsuit caused the decision, and it would be premature to draw that conclusion.

But the development makes one feature of the lawsuit even more important.

One of the defendants, Dr. Jennifer Daily, is Racing Louisville's chief medical officer. But Daily is not a Racing Louisville employee. She serves the club through its contractual relationship with UofL Health, which has been Racing Louisville's official sports-medicine partner.

That distinction is easy to miss—and potentially significant.

When fans hear “team doctor” or “chief medical officer,” the natural assumption is that the physician works for the team. In modern professional sports, the actual structure can be considerably more complicated.

A club may outsource substantial portions of player medical care to a hospital system or outside medical practice. The physician treating the athlete may therefore occupy several roles at once: doctor to the player, medical adviser to the club, employee of an outside health system, and participant in league-mandated medical protocols.

DeMelo's case puts that structure under a microscope.

Her complaint alleges that UofL Health and its physicians failed to properly diagnose and treat the cardiac condition that preceded her September 2025 cardiac arrest. Racing Louisville itself is not a defendant, and the lawsuit does not accuse the club of wrongdoing. But the physicians whose care is challenged were providing medical services within the system the club selected for its players.

That is why the reported end of the UofL Health relationship matters even if it never becomes evidence in the case.

A professional team's agreement with an outside medical provider is not merely a sponsorship arrangement with a logo attached.

It allocates responsibility.

Who selects the doctors? Who employs them? Who has final authority over return-to-play decisions? What information must be communicated to team personnel? Who bears liability if something goes wrong? Who provides insurance and indemnification? And what happens when the interests of the athlete, physician and club do not perfectly align?

Those questions usually remain invisible because the system operates quietly in the background.

A case like DeMelo's makes them visible.

And if Racing Louisville does move to a different medical provider after this season, the club will not simply be changing sponsors. It will be rebuilding part of the infrastructure responsible for evaluating, treating and clearing professional athletes to compete.

That is a meaningful business and governance decision.

DeMelo's lawsuit is ultimately a medical-negligence case against UofL Health and two physicians. The allegations remain allegations, and the defendants have not yet had their claims adjudicated.

But the dispute also exposes a broader question professional sports increasingly will have to confront:

When a team outsources medical care, it can outsource the employment relationship. It cannot outsource the importance of the care its athletes receive.

The distinction between the team's doctor and a doctor employed by the team may sound semantic.

In litigation, contracts, insurance, accountability and athlete welfare, it can be everything.